The use of botulinum toxin type A in spastic diplegia due to cerebral palsy

European Journal of Neurology

Volumn 6, Issue SUPPL. 4, 1999, Pages s95-s98

  Ward, Anthony B ^a  

^a Staffordshire Rheumatology Centre   (United Kingdom)

Author keywords

Botulinum toxin type A injection; Outcome measures; Spastic diplegia

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; BODY MOVEMENT; CEREBRAL PALSY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; DRUG EFFICACY; FOLLOW UP; GAIT; HUMAN; INJURY SCALE; PILOT STUDY; PRIORITY JOURNAL; PSOAS MUSCLE; SCORING SYSTEM; SOLEUS MUSCLE; SPASTICITY; THIGH; TOE JOINT; TREATMENT OUTCOME; WALKING;

EID: 0033395173     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1999.tb00043.x     Document Type: Conference Paper

References (4)

1. Aung TS, Boughey AM, Ward AB (1994). A study of the North Staffordshire Young Adult Service for physically handicapped school leavers and young adults. Clin Rehab 8:147-153.
2. Cosgrove AP, Graham HK (1994). Botulinum toxin prevents the development of contractures in the hereditary spastic mouse with cerebral palsy. Dev Med Child Neurol 36:379-385.
3. Cosgrove AP, Corry IS, Graham HK (1994). Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 36:386-396.
4. Gage JR, Fabian D, Hicks R, Tashman S (1984). Pre- and post-operative gait analysis in patients with spastic diplegia: a preliminary report. J Pediatr Orthopedics 4:715-725.